Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb 22:7:61.
doi: 10.3389/fimmu.2016.00061. eCollection 2016.

Immunological Landscape and Clinical Management of Rectal Cancer

Affiliations
Review

Immunological Landscape and Clinical Management of Rectal Cancer

Elísabeth Pérez-Ruiz et al. Front Immunol. .

Abstract

The clinical management of rectal cancer and colon cancer differs due to increased local relapses in rectal cancer. However, the current molecular classification does not differentiate rectal cancer and colon cancer as two different entities. In recent years, the impact of the specific immune microenvironment in cancer has attracted renewed interest and is currently recognized as one of the major determinants of clinical progression in a wide range of tumors. In colorectal cancer, the density of lymphocytic infiltration is associated with better overall survival. Due to the need for biomarkers of response to conventional treatment with chemoradiotherapy in rectal tumors, the immune status of rectal cancer emerges as a useful tool to improve the management of patients.

Keywords: chemotherapy; immune system; predictive factors; radiotherapy; rectal cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Molecular biomarkers of right and left colorectal tumors. The recent consensus of CRC subtypes describe four types of CRC. The characteristics of CMS1 and CMS2 are very similar to the right and left tumors, respectively.

Similar articles

Cited by

References

    1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 64:104–17.10.3322/caac.21220 - DOI - PubMed
    1. Clinical Outcomes of Surgical Therapy Study G. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med (2004) 350:2050–9.10.1056/NEJMoa032651 - DOI - PubMed
    1. Bonadeo FA, Vaccaro CA, Benati ML, Quintana GM, Garione XE, Telenta MT. Rectal cancer: local recurrence after surgery without radiotherapy. Dis Colon Rectum (2001) 44:374–9.10.1007/BF02234736 - DOI - PubMed
    1. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med (2004) 351:1731–40.10.1056/NEJMoa040694 - DOI - PubMed
    1. Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol (2006) 24:4620–5.10.1200/JCO.2006.06.7629 - DOI - PubMed

LinkOut - more resources